{"protocolSection": {"identificationModule": {"nctId": "NCT03099655", "orgStudyIdInfo": {"id": "Attain Stability Quad"}, "organization": {"fullName": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}, "briefTitle": "Attain Stability\u2122 Quad Clinical Study", "officialTitle": "Attain Stability\u2122 Quad Clinical Study"}, "statusModule": {"statusVerifiedDate": "2019-12", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-07-07", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2018-08-02", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-05-31", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-03-14", "studyFirstSubmitQcDate": "2017-03-28", "studyFirstPostDateStruct": {"date": "2017-04-04", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2019-11-08", "resultsFirstSubmitQcDate": "2019-12-19", "resultsFirstPostDateStruct": {"date": "2020-01-09", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-12-19", "lastUpdatePostDateStruct": {"date": "2020-01-09", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true, "isUnapprovedDevice": true}, "descriptionModule": {"briefSummary": "The purpose of this clinical study is to evaluate the safety and efficacy of the Attain Stability Quadripolar MRI SureScan Left Ventricular (LV) lead (Model 4798).", "detailedDescription": "The Attain Stability Quad Clinical Study is a prospective, non-randomized, multi-site, global, investigational Device Exemption (IDE), interventional clinical study. The purpose of this clinical study is to evaluate the safety and efficacy of the Attain Stability\u2122 Quad MRI SureScan LV Lead (Model 4798). This will be assessed through a primary safety and primary efficacy endpoints.\n\nAll subjects included in the study will be implanted with a Medtronic market released de novo CRT-P or CRT-D device, compatible market released Medtronic RA and Medtronic RV leads and an Attain Stability Quad MRI SureScan LV Lead (Model 4798).\n\nUp to 471 subjects will be enrolled into the study and up to 471 Attain Stability Quad MRI SureScan LV Lead (Model 4798) implanted, to ensure a minimum effective sample size of 400 Model 4798 leads implanted with 6 months post implant follow up visits (assuming 15% attrition) at up to 56 sites worldwide."}, "conditionsModule": {"conditions": ["Heart Failure"], "keywords": ["Heart Failure", "Cardiac Pacing", "Cardiac Resynchronization Therapy", "Left Ventricular Lead"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "interventionModelDescription": "The Medtronic Attain Stability Quad MRI SureScan (Model 4798) is a steroid-eluting, quadripolar electrode, transvenous, over-the-wire (OTW), IS4-LLLL compatible, active fixation, cardiac vein pacing LV lead. This lead is similar to the Attain Performa family of quadripolar leads (Models 4298, 4398, and 4598) but also has a side helix for active fixation which is similar to the Attain Stability bipolar lead (Model 20066/4796) (available outside of the United States).", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 471, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Attain Stability Quad Lead", "type": "EXPERIMENTAL", "description": "Attain Stability Quad Lead (Model 4798) - Single arm study.", "interventionNames": ["Device: Attain Stability Quad Left Ventricular Pacing Lead"]}], "interventions": [{"type": "DEVICE", "name": "Attain Stability Quad Left Ventricular Pacing Lead", "description": "cardiac stimulation", "armGroupLabels": ["Attain Stability Quad Lead"], "otherNames": ["4798 Lead"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Lead Complication-free Rate at 6 Months", "description": "Subjects free of Model 4798 lead-related complications at 6 months post-implant\n\n-Model 4798 lead will be considered safe if the probability of subjects free from Attain Stability Quad lead-related complications at 6-months post implant is greater than 87% (i.e. the one-sided 97.5% lower confidence bound must be greater than 87%). Complications were defined in the protocol as, \"An adverse event that includes the following is considered a complication: Results in death, Involves any termination of significant device function, or Requires an invasive intervention\". Relationship of complication to the Attain Stability Quad lead was determined by an independent Clinical Events Committee.", "timeFrame": "Implant to 6 months post-implant"}, {"measure": "Proportion (Reported as a Percent) of Subjects With at Least One Vector Having PCT \u22642.5 V at 0.5 ms Pulse Width and Absence of Phrenic Nerve Stimulation (PNS)", "description": "The Model 4798 LV lead has sixteen (16) programmable pacing vectors. The endpoint for the primary efficacy objective is whether or not there is at least one Model 4798 LV lead pacing vector with pacing capture voltage thresholds less than or equal to 2.5V.\n\n-Model 4798 lead will be considered effective if the proportion of subjects with at least one Model 4798 LV lead pacing vector with pacing capture voltage thresholds less than or equal to 2.5V at 0.5 ms pulse width (with absence of Phrenic Nerve Stimulation at 5.0 V) at 6 months post-implant is greater than 80%.", "timeFrame": "6 months post-implant"}, {"measure": "Proportion (Reported as a Percent) of Subjects With at Least One Extra Vector Having PCT \u2264 4.0V at 0.5 ms Pulse Width and Absence of Phrenic Nerve Stimulation (PNS)", "description": "The co-primary efficacy endpoint is whether or not a second Model 4798 lead configuration has a pacing capture threshold less than or equal to 4V, excluding the pacing vector that is already counted to the primary efficacy.\n\n-Model 4798 lead will be considered effective if the proportion of subjects with at least one additional Model 4798 LV lead pacing vector with pacing capture voltage thresholds less than or equal to 4.0 V at 0.5 ms pulse width (with absence of Phrenic Nerve Stimulation at 5.0 V) at 6 months post-implant is greater than 80%.", "timeFrame": "6 months post-implant"}], "secondaryOutcomes": [{"measure": "Implant Success", "description": "Number of Attain Stability leads successfully implanted subjects divided by number of subjects undergo Attain Stability lead implant procedure", "timeFrame": "During procedure"}, {"measure": "Implant Duration", "description": "Summary statistics including mean and standard deviation will be obtained for total implant procedure time (minutes), fluoroscopy time, and cannulation time for each successful implant procedure.", "timeFrame": "During procedure"}, {"measure": "LV Pacing Capture Threshold (PCT) at 6 Months", "description": "Summary statistics including mean and standard deviation will be obtained for PCT (volt) measured at 6-month post implant visit for each successful implanted subject with valid pacing data collected at 6 months post implant follow-up visit.", "timeFrame": "Implant to 6 months post-implant"}, {"measure": "LV Impedance at 6 Months", "description": "Summary statistics including mean and standard deviation will be obtained for Pacing Impedance (Ohm) measured at 6-month post implant visit for each successful implanted subject", "timeFrame": "Implant to 6 months"}, {"measure": "Post Implant Lead Failure Rate", "description": "Number of subjects with a given complication from implant through 6 months (183 days) by total number of subjects undergo Attain Stability implant procedure", "timeFrame": "Implant to 6 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patient meets CRT implant criteria as determined by local regulatory and/or hospital policy (i.e. US subjects should meet CRT device indications per the HRS/ACC/AHA guidelines)\n* Patient (or legally authorized representative) has signed and dated the study-specific Informed Consent Form\n* Patient is 18 years of age or older, or is of legal age to give informed consent per local and national law\n* Patient is expected to remain available for follow-up visits\n\nExclusion Criteria:\n\n* Patient has had a previous unsuccessful LV lead implant attempt\n* Patient has a previous CRT system or LV lead implanted (for example, transvenous or epicardial)\n* Patient is currently implanted with a recalled (i.e. market-withdrawn, recalled or safety alert) RA and/or RV lead\n* Patient has known coronary venous vasculature that is inadequate for lead placement\n* Patient has unstable angina pectoris or has had an acute myocardial infarction (MI) within the past 30 days\n* Patient has had a coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the past 90 days\n* Patient has contraindications for standard transvenous cardiac pacing (e.g., mechanical right heart valve)\n* Patient has had a heart transplant (patients waiting for heart transplants are allowed in the study)\n* Patient has known renal insufficiency that would prevent them from receiving an occlusive venogram during the implant procedure\n* Patient is contraindicated for \\<1mg dexamethasone acetate\n* Patient is enrolled in any concurrent drug and/or device study that may confound the results of this study\n* Patient has a terminal illness and is not expected to survive more than six months\n* Patient meets exclusion criteria required by local law (e.g. age, pregnancy, breast feeding, etc.)\n* Patient is unable to tolerate an urgent thoracotomy", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "George Crossley III, MD", "affiliation": "Vanderbilt University Medical Center", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Phoenix Cardiovascular Research Group, LLC", "city": "Phoenix", "state": "Arizona", "zip": "85006", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "Sequoia Hospital", "city": "East Palo Alto", "state": "California", "zip": "94062", "country": "United States", "geoPoint": {"lat": 37.46883, "lon": -122.14108}}, {"facility": "Torrance Memorial Medical Center", "city": "Torrance", "state": "California", "zip": "90505", "country": "United States", "geoPoint": {"lat": 33.83585, "lon": -118.34063}}, {"facility": "Hartford Hospital", "city": "Hartford", "state": "Connecticut", "zip": "06102", "country": "United States", "geoPoint": {"lat": 41.76371, "lon": -72.68509}}, {"facility": "Yale New Haven Hospital", "city": "New Haven", "state": "Connecticut", "zip": "06520", "country": "United States", "geoPoint": {"lat": 41.30815, "lon": -72.92816}}, {"facility": "Baptist Heart Specialists Pavilion Office", "city": "Jacksonville", "state": "Florida", "zip": "32216", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"facility": "Emory University Hospital", "city": "Atlanta", "state": "Georgia", "zip": "30308", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Piedmont Heart Institute", "city": "Atlanta", "state": "Georgia", "zip": "30309", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Prairie Education & Research Cooperative (Springfield IL)", "city": "Springfield", "state": "Illinois", "zip": "62701", "country": "United States", "geoPoint": {"lat": 39.80172, "lon": -89.64371}}, {"facility": "Iowa Heart Center (West Des Moines IA)", "city": "West Des Moines", "state": "Iowa", "zip": "50266", "country": "United States", "geoPoint": {"lat": 41.57721, "lon": -93.71133}}, {"facility": "Delmarva Heart Research Foundation Inc", "city": "Salisbury", "state": "Maryland", "zip": "21804", "country": "United States", "geoPoint": {"lat": 38.36067, "lon": -75.59937}}, {"facility": "DLP Marquette Physicians Practices Inc", "city": "Marquette", "state": "Michigan", "zip": "49855", "country": "United States", "geoPoint": {"lat": 46.54354, "lon": -87.39542}}, {"facility": "Minneapolis Heart Institute Foundation", "city": "Minneapolis", "state": "Minnesota", "zip": "55407", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "CentraCare Heart & Vascular Center", "city": "Saint Cloud", "state": "Minnesota", "zip": "56303", "country": "United States", "geoPoint": {"lat": 45.5608, "lon": -94.16249}}, {"facility": "HealthPartners Institute (Saint Louis Park MN)", "city": "Saint Louis Park", "state": "Minnesota", "zip": "55426", "country": "United States", "geoPoint": {"lat": 44.9483, "lon": -93.34801}}, {"facility": "Morristown Memorial Hospital", "city": "Morristown", "state": "New Jersey", "zip": "07960", "country": "United States", "geoPoint": {"lat": 40.79677, "lon": -74.48154}}, {"facility": "The Valley Hospital", "city": "Ridgewood", "state": "New Jersey", "zip": "07450", "country": "United States", "geoPoint": {"lat": 40.97926, "lon": -74.11653}}, {"facility": "Lourdes Cardiology Services", "city": "Voorhees", "state": "New Jersey", "zip": "08043", "country": "United States", "geoPoint": {"lat": 40.48122, "lon": -74.48321}}, {"facility": "Asheville Cardiology Associates", "city": "Asheville", "state": "North Carolina", "zip": "28803", "country": "United States", "geoPoint": {"lat": 35.60095, "lon": -82.55402}}, {"facility": "Carolinas Medical Center", "city": "Charlotte", "state": "North Carolina", "zip": "28203", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"facility": "Duke University Medical Center (DUMC)", "city": "Durham", "state": "North Carolina", "zip": "27710", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "The Lindner Research Center", "city": "Cincinnati", "state": "Ohio", "zip": "45219", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"facility": "Cleveland Clinic", "city": "Cleveland", "state": "Ohio", "zip": "44195", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "The Ohio State University Wexner Medical Center", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "Oklahoma Heart Hospital Research Foundation", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73120", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "Oklahoma Heart Institute", "city": "Tulsa", "state": "Oklahoma", "zip": "74104", "country": "United States", "geoPoint": {"lat": 36.15398, "lon": -95.99277}}, {"facility": "Sutherland Cardiology Clinic", "city": "Memphis", "state": "Tennessee", "zip": "38103", "country": "United States", "geoPoint": {"lat": 35.14953, "lon": -90.04898}}, {"facility": "Centennial Heart Cardiovascular Consultants L", "city": "Nashville", "state": "Tennessee", "zip": "37203", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "Vanderbilt University Medical Center", "city": "Nashville", "state": "Tennessee", "zip": "37232", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "Texas Cardiac Arrhythmia Research Foundation", "city": "Austin", "state": "Texas", "zip": "78705", "country": "United States", "geoPoint": {"lat": 30.26715, "lon": -97.74306}}, {"facility": "Baylor Research Institute (Plano TX)", "city": "Dallas", "state": "Texas", "zip": "75226", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "CHI Saint Luke's Health - Baylor Saint Luke's Medical Center", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Sentara Norfolk General Hospital", "city": "Norfolk", "state": "Virginia", "zip": "23507", "country": "United States", "geoPoint": {"lat": 36.84681, "lon": -76.28522}}, {"facility": "Kootenai Heart Clinics Northwest", "city": "Spokane", "state": "Washington", "zip": "99204", "country": "United States", "geoPoint": {"lat": 47.65966, "lon": -117.42908}}, {"facility": "Aurora Saint Luke's Medical Center", "city": "Milwaukee", "state": "Wisconsin", "zip": "53215", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}, {"facility": "University of Calgary", "city": "Calgary", "zip": "T2N 4N1", "country": "Canada", "geoPoint": {"lat": 51.05011, "lon": -114.08529}}, {"facility": "London Health Sciences Centre - University Campus", "city": "London", "zip": "N6A 5A5", "country": "Canada", "geoPoint": {"lat": 42.98339, "lon": -81.23304}}, {"facility": "Southlake Regional Health Centre", "city": "Newmarket", "zip": "L3Y 8C3", "country": "Canada", "geoPoint": {"lat": 44.05011, "lon": -79.46631}}, {"facility": "Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec (IUCPQ)", "city": "Quebec", "zip": "G1V 4G5", "country": "Canada", "geoPoint": {"lat": 46.81228, "lon": -71.21454}}, {"facility": "Klinik f\u00fcr Herzchirurgie Karlsruhe", "city": "Karlsruhe", "zip": "76185", "country": "Germany", "geoPoint": {"lat": 49.00937, "lon": 8.40444}}, {"facility": "Berufsgenossenschaftliche Universit\u00e4tsklinik Bergmannsheil GmbH", "city": "L\u00fcdenscheid", "zip": "58515", "country": "Germany", "geoPoint": {"lat": 51.21977, "lon": 7.6273}}, {"facility": "Prince of Wales Hospital", "city": "Hong Kong", "country": "Hong Kong", "geoPoint": {"lat": 22.27832, "lon": 114.17469}}, {"facility": "Azienda Ospedaliero-Universitaria Pisana - Stabilimento di Cisanello", "city": "Pisa", "zip": "56100", "country": "Italy", "geoPoint": {"lat": 43.70853, "lon": 10.4036}}, {"facility": "Institut Jantung Negara - National Heart Institute", "city": "Kuala Lumpur", "zip": "50400", "country": "Malaysia", "geoPoint": {"lat": 3.1412, "lon": 101.68653}}, {"facility": "Catharina Ziekenhuis", "city": "Eindhoven", "zip": "5623 EJ", "country": "Netherlands", "geoPoint": {"lat": 51.44083, "lon": 5.47778}}, {"facility": "Isala Zwolle", "city": "Zwolle", "zip": "8011 JW", "country": "Netherlands", "geoPoint": {"lat": 52.5125, "lon": 6.09444}}, {"facility": "Helse Bergen HF - Haukeland Universitetssjukehus", "city": "Bergen", "zip": "5021", "country": "Norway", "geoPoint": {"lat": 60.39299, "lon": 5.32415}}, {"facility": "Hospital Universitario Ram\u00f3n y Cajal", "city": "Madrid", "zip": "28050", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"facility": "Hospital Cl\u00ednico Universitario de Valladolid", "city": "Valladolid", "zip": "47006", "country": "Spain", "geoPoint": {"lat": 41.65518, "lon": -4.72372}}, {"facility": "Karolinska Universitetssjukhuset", "city": "Stockholm", "zip": "17176", "country": "Sweden", "geoPoint": {"lat": 59.33258, "lon": 18.0649}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Out of 471 initial enrollments;31 were excluded due to the following:\n\n1. No implant attempted(23)\n2. Investigator deemed not medically necessary(4)\n3. Insurance declined coverage(2)\n4. Patient did not meet criteria for the study(1)\n5. Investigator withdrew, not a good candidate(1)\n\nResulting in 440 subjects with 4798 Lead implant attempted", "groups": [{"id": "FG000", "title": "Attain Stability Quad Lead", "description": "Attain Stability Quad Lead (Model 4798) - Single arm study.\n\nAttain Stability Quad Left Ventricular Pacing Lead: cardiac stimulation"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "440"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "6-Month visit with original 4798 lead implanted", "numSubjects": "379"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "61"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Subjects with an attempted Attain Stability Quad LV Lead implant", "groups": [{"id": "BG000", "title": "Attain Stability Quad Lead", "description": "Patients with an implant attempt for the Attain Stability Quad Lead (Model 4798)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "440"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "70", "spread": "11"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "111"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "329"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "1"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "26"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "28"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "312"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "73"}]}]}]}, {"title": "Region of Enrollment", "description": "Subjects with an attempted Attain Stability Quad LV Lead implant", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Canada", "categories": [{"measurements": [{"groupId": "BG000", "value": "37"}]}]}, {"title": "Netherlands", "categories": [{"measurements": [{"groupId": "BG000", "value": "23"}]}]}, {"title": "Sweden", "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}]}]}, {"title": "Hong Kong", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}, {"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "314"}]}]}, {"title": "Norway", "categories": [{"measurements": [{"groupId": "BG000", "value": "15"}]}]}, {"title": "Italy", "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}]}]}, {"title": "Malaysia", "categories": [{"measurements": [{"groupId": "BG000", "value": "23"}]}]}, {"title": "Germany", "categories": [{"measurements": [{"groupId": "BG000", "value": "12"}]}]}, {"title": "Spain", "categories": [{"measurements": [{"groupId": "BG000", "value": "9"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Lead Complication-free Rate at 6 Months", "description": "Subjects free of Model 4798 lead-related complications at 6 months post-implant\n\n-Model 4798 lead will be considered safe if the probability of subjects free from Attain Stability Quad lead-related complications at 6-months post implant is greater than 87% (i.e. the one-sided 97.5% lower confidence bound must be greater than 87%). Complications were defined in the protocol as, \"An adverse event that includes the following is considered a complication: Results in death, Involves any termination of significant device function, or Requires an invasive intervention\". Relationship of complication to the Attain Stability Quad lead was determined by an independent Clinical Events Committee.", "populationDescription": "Subjects with an attempted Attain Stability Quad Lead Model implant, results come from PMA-S Clinical Report Version 3, 28MAR2019.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "97.5% Confidence Interval", "unitOfMeasure": "Survival Probability (% of subjects)", "timeFrame": "Implant to 6 months post-implant", "groups": [{"id": "OG000", "title": "Attain Stability Quad Lead", "description": "Patients with an implant attempt for the Attain Stability Quad Lead (Model 4798)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "440"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "97.59", "lowerLimit": "96.12", "upperLimit": "100"}]}]}]}, {"type": "PRIMARY", "title": "Proportion (Reported as a Percent) of Subjects With at Least One Vector Having PCT \u22642.5 V at 0.5 ms Pulse Width and Absence of Phrenic Nerve Stimulation (PNS)", "description": "The Model 4798 LV lead has sixteen (16) programmable pacing vectors. The endpoint for the primary efficacy objective is whether or not there is at least one Model 4798 LV lead pacing vector with pacing capture voltage thresholds less than or equal to 2.5V.\n\n-Model 4798 lead will be considered effective if the proportion of subjects with at least one Model 4798 LV lead pacing vector with pacing capture voltage thresholds less than or equal to 2.5V at 0.5 ms pulse width (with absence of Phrenic Nerve Stimulation at 5.0 V) at 6 months post-implant is greater than 80%.", "populationDescription": "Subjects with an attempted Attain Stability Quad Lead Model implant, results come from PMA-S Clinical Report Version 3, 28MAR2019.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "97.5% Confidence Interval", "unitOfMeasure": "Percent of Subjects", "timeFrame": "6 months post-implant", "groups": [{"id": "OG000", "title": "Attain Stability Quad Lead", "description": "All subjects who are successfully implanted with Model 4798 lead and with valid pacing data collected at 6 months post-implant follow-up visit."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "377"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "96.29", "lowerLimit": "93.85", "upperLimit": "100"}]}]}]}, {"type": "PRIMARY", "title": "Proportion (Reported as a Percent) of Subjects With at Least One Extra Vector Having PCT \u2264 4.0V at 0.5 ms Pulse Width and Absence of Phrenic Nerve Stimulation (PNS)", "description": "The co-primary efficacy endpoint is whether or not a second Model 4798 lead configuration has a pacing capture threshold less than or equal to 4V, excluding the pacing vector that is already counted to the primary efficacy.\n\n-Model 4798 lead will be considered effective if the proportion of subjects with at least one additional Model 4798 LV lead pacing vector with pacing capture voltage thresholds less than or equal to 4.0 V at 0.5 ms pulse width (with absence of Phrenic Nerve Stimulation at 5.0 V) at 6 months post-implant is greater than 80%.", "populationDescription": "All subjects who are successfully implanted with a Model 4798 lead and with valid pacing data collected 6 months post-implant follow-up visit.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "97.5% Confidence Interval", "unitOfMeasure": "Percent of Subjects", "timeFrame": "6 months post-implant", "groups": [{"id": "OG000", "title": "Attain Stability Quad Lead", "description": "Patients with an implant attempt for the Attain Stability Quad Lead (Model 4798)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "377"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "94.16", "lowerLimit": "91.30", "upperLimit": "100"}]}]}]}, {"type": "SECONDARY", "title": "Implant Success", "description": "Number of Attain Stability leads successfully implanted subjects divided by number of subjects undergo Attain Stability lead implant procedure", "populationDescription": "Subjects with an attempted Attain Stability Quad Lead Model implant, results come from PMA-S Clinical Report Version 3, 28MAR2019.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percent of Subjects", "timeFrame": "During procedure", "groups": [{"id": "OG000", "title": "Attain Stability Quad Lead", "description": "Patients with an implant attempt for the Attain Stability Quad Lead (Model 4798)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "440"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "96.8", "lowerLimit": "94.7", "upperLimit": "98.3"}]}]}]}, {"type": "SECONDARY", "title": "Implant Duration", "description": "Summary statistics including mean and standard deviation will be obtained for total implant procedure time (minutes), fluoroscopy time, and cannulation time for each successful implant procedure.", "populationDescription": "Subjects with a successfully implanted Attain Stability Quad Lead Model implant, results come from PMA-S Clinical Report Version 3, 28MAR2019.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Minutes", "timeFrame": "During procedure", "groups": [{"id": "OG000", "title": "Attain Stability Quad Lead", "description": "All subjects who are successfully implanted with a Model 4798 lead and with valid pacing data collected at 6 months post implant follow-up visit."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "426"}]}], "classes": [{"title": "Implant Procedure Time", "categories": [{"measurements": [{"groupId": "OG000", "value": "93", "spread": "40"}]}]}, {"title": "Fluoroscopy", "categories": [{"measurements": [{"groupId": "OG000", "value": "19", "spread": "15"}]}]}, {"title": "Cannulation", "categories": [{"measurements": [{"groupId": "OG000", "value": "7", "spread": "11"}]}]}]}, {"type": "SECONDARY", "title": "LV Pacing Capture Threshold (PCT) at 6 Months", "description": "Summary statistics including mean and standard deviation will be obtained for PCT (volt) measured at 6-month post implant visit for each successful implanted subject with valid pacing data collected at 6 months post implant follow-up visit.", "populationDescription": "Subjects with a successfully implanted Attain Stability Quad Lead Model implant, results come from PMA-S Clinical Report Version 3, 28MAR2019.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Volts", "timeFrame": "Implant to 6 months post-implant", "groups": [{"id": "OG000", "title": "Attain Stability Quad Lead", "description": "All subjects who are successfully implanted with a Model 4798 lead and with valid pacing data collected at 6 months post implant follow-up visit."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "426"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.07", "spread": "0.68"}]}]}]}, {"type": "SECONDARY", "title": "LV Impedance at 6 Months", "description": "Summary statistics including mean and standard deviation will be obtained for Pacing Impedance (Ohm) measured at 6-month post implant visit for each successful implanted subject", "populationDescription": "Subjects with a successfully implanted Attain Stability Quad Lead Model implant, results come from PMA-S Clinical Report Version 3, 28MAR2019.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Ohms", "timeFrame": "Implant to 6 months", "groups": [{"id": "OG000", "title": "Attain Stability Quad Lead", "description": "All subjects who are successfully implanted with a Model 4798 lead and with valid pacing data collected at 6 months post implant follow-up visit."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "426"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "557.7", "spread": "179.5"}]}]}]}, {"type": "SECONDARY", "title": "Post Implant Lead Failure Rate", "description": "Number of subjects with a given complication from implant through 6 months (183 days) by total number of subjects undergo Attain Stability implant procedure", "populationDescription": "Subjects with an attempted Attain Stability Quad Lead Model implant, results come from PMA-S Clinical Report Version 3, 28MAR2019.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percent of Subjects", "timeFrame": "Implant to 6 months", "groups": [{"id": "OG000", "title": "Attain Stability Quad Lead", "description": "All subjects who are successfully implanted with a Model 4798 lead."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "426"}]}], "classes": [{"title": "Device Connection Issue", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.23", "lowerLimit": "0.01", "upperLimit": "1.30"}]}]}, {"title": "Device Pacing Issue", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.23", "lowerLimit": "0.01", "upperLimit": "1.30"}]}]}, {"title": "Device Stimulation Issue", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.70", "lowerLimit": "0.15", "upperLimit": "2.20"}]}]}, {"title": "Lead Dislodgement", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.70", "lowerLimit": "0.15", "upperLimit": "2.20"}]}]}, {"title": "Infection", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.23", "lowerLimit": "0.01", "upperLimit": "1.30"}]}]}, {"title": "Ventricular Tachycardia", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.23", "lowerLimit": "0.01", "upperLimit": "1.30"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Date of implant (or attempted implant) through study completion, an average of 6.42 months.", "eventGroups": [{"id": "EG000", "title": "Attain Stability Quad Lead", "description": "Patients with an implant attempt for the Attain Stability Quad Lead (Model 4798)", "deathsNumAffected": 22, "deathsNumAtRisk": 440, "seriousNumAffected": 147, "seriousNumAtRisk": 440, "otherNumAffected": 27, "otherNumAtRisk": 440}], "seriousEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 440}]}, {"term": "Haemorrhagic anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Iron deficiency anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Thrombocytopenia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Acute left ventricular failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 440}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Aortic valve stenosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 16, "numAtRisk": 440}]}, {"term": "Atrial flutter", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 440}]}, {"term": "Bradycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 440}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 12, "numAffected": 11, "numAtRisk": 440}]}, {"term": "Cardiac failure acute", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 21, "numAffected": 18, "numAtRisk": 440}]}, {"term": "Cardiac failure chronic", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 15, "numAtRisk": 440}]}, {"term": "Cardiac perforation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Cardiac tamponade", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Hypertensive heart disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Palpitations", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Pericardial effusion", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Pericarditis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Pulseless electrical activity", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Ventricular extrasystoles", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Ventricular fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Ventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 9, "numAtRisk": 440}]}, {"term": "Gastrointestinal arteriovenous malformation", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Inner ear disorder", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Retinal artery occlusion", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Femoral hernia incarcerated", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 440}]}, {"term": "Inguinal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Inguinal hernia, obstructive", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Upper gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 440}]}, {"term": "Death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Hernia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Implant site haematoma", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 440}]}, {"term": "Implant site pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 440}]}, {"term": "Sudden cardiac death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Cholecystitis acute", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Cholelithiasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Amyloidosis", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Bacteraemia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 440}]}, {"term": "Diverticulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Gangrene", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Implant site infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Osteomyelitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Periorbital cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Pneumococcal sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 9, "numAtRisk": 440}]}, {"term": "Pneumonia viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Pyelitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Septic shock", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 440}]}, {"term": "Staphylococcal bacteraemia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Staphylococcal sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 440}]}, {"term": "Cardiac vein perforation", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Femoral neck fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 440}]}, {"term": "Femur fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Incision site inflammation", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Lumbar vertebral fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Meniscus injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Post procedural haematoma", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Rib fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Road traffic accident", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Subarachnoid haemorrhage", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Toxicity to various agents", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Clostridium test positive", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 440}]}, {"term": "International normalised ratio increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "White blood cell count increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Hyponatraemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Hypovolaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Obesity", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Gouty arthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Lung neoplasm malignant", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Metastases to spinal cord", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Encephalopathy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Metabolic encephalopathy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Presyncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Seizure", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Spinal cord compression", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 440}]}, {"term": "Device connection issue", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Device inappropriate shock delivery", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Device pacing issue", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 440}]}, {"term": "Device stimulation issue", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 440}]}, {"term": "Lead dislodgement", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 12, "numAffected": 12, "numAtRisk": 440}]}, {"term": "Oversensing", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Acute kidney injury", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 10, "numAtRisk": 440}]}, {"term": "End stage renal disease", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Haematuria", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Nephropathy", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Renal impairment", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Acute respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Epistaxis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Haemoptysis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Pleural effusion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Pneumonia aspiration", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 440}]}, {"term": "Pneumothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Pulmonary embolism", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Medical device change", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Dry gangrene", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Femoral artery embolism", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Hypertensive emergency", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 440}]}, {"term": "Intermittent claudication", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 440}]}, {"term": "Peripheral arterial occlusive disease", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Peripheral ischaemia", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}, {"term": "Peripheral vascular disorder", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 440}]}], "otherEvents": [{"term": "Device stimulation issue", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 21.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 31, "numAffected": 27, "numAtRisk": 440}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true}, "pointOfContact": {"title": "Erika Pouliot", "organization": "Medtronic", "email": "erika.pouliot@medtronic.com", "phone": "+17635261270"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2017-07-25", "uploadDate": "2019-11-08T11:25", "filename": "SAP_000.pdf", "size": 365630}, {"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2017-03-20", "uploadDate": "2019-11-08T11:58", "filename": "Prot_001.pdf", "size": 4730263}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}